CIIT vs VRTX · rev $9.3M vs P/E 30, rev $12.00B
Tianci International, Inc. Common Stock (CIIT) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
Tianci International, Inc. Common Stock (CIIT) is a integrated freight & logistics company listed on NASDAQ.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported CIIT revenue for 2025-07-31 was $9.3M. Net income was -$2.7M. Revenue was up 7.7% from 2024-07-31 to 2025-07-31. CIIT currently screens at market cap $2.1M.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
CIIT currently screens at market cap $2.1M. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the CIIT and VRTX stock pages for the full models.
Not investment advice.